Continuous Glucose Monitoring Sensors: Past, Present and Future Algorithmic Challenges
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
Continuous glucose monitoring (CGM) sensors are portable devices that allow measuring and visualizing the glucose concentration in real time almost continuously for several days and are provided with hypo/hyperglycemic alerts and glucose trend information. CGM sensors have revolutionized Type 1 diabetes (T1D) management, improving glucose control when used adjunctively to self-monitoring blood glucose systems. Furthermore, CGM devices have stimulated the development of applications that were impossible to create without a continuous-time glucose signal, e.g., real-time predictive alerts of hypo/hyperglycemic episodes based on the prediction of future glucose concentration, automatic basal insulin attenuation methods for hypoglycemia prevention, and the artificial pancreas. However, CGM sensors’ lack of accuracy and reliability limited their usability in the clinical practice, calling upon the academic community for the development of suitable signal processing methods to improve CGM performance. The aim of this paper is to review the past and present algorithmic challenges of CGM sensors, to show how they have been tackled by our research group, and to identify the possible future ones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 The smart CGM sensor architecture, which consists of placing, in cascade to the output of a commercial CGM sensor, three software modules, able to work in real time, for denoising the random noise component, enhancing the accuracy, and predicting the future glucose concentration (adapted from [27]).](https://figures.cochat.ai/paper-figures/c1dcdb45c40842afa0dbc799604b1883/continuous-glucose-monitoring-sensors-past-present-and-future-algorithmic-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The accuracy of CGM devices has improved significantly over time, with manufacturers of current devices reporting mean absolute relative deviation (MARD) proportions of 8.1% to 12.3%, compared with 5% to 10% for current BGM devices (and 22% for the first intermittently read interstitial glucose monitor brought to market in 2001) (190).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [190]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
The UVA/PADOVA Type 1 Diabetes Simulator: New Features
Man, C. D., Micheletto, F., Lv, D., Breton, M., Kovatchev, B., & Cobelli, C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813514502 · Cited by 791 · cited 1×
“The UVA/Padova T1D simulator is a large-scale maximal computer model of glucose, insulin and glucagon dynamics in patients with T1D, described by 13 differential equations and provided with three different populations: 100 adult, 100 pediatric and 100 adolescent virtual subjects [52,53].”
BackgroundIn Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760 · cited 1×
“The UVA/Padova T1D simulator is a large-scale maximal computer model of glucose, insulin and glucagon dynamics in patients with T1D, described by 13 differential equations and provided with three different populations: 100 adult, 100 pediatric and 100 adolescent virtual subjects [52,53].”
BackgroundThe Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 1×
“The reduction/elimination of calibrations in CGM systems is further pressured by the recent advent of the Abbott Freestyle Libre (Abbott Diabetes Care, Alameda, CA, USA) [62,63].”
MethodSparacino, G., Zanderigo, F., Corazza, S., Maran, A., Facchinetti, A., & Cobelli, C. (2007) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2006.889774 · Cited by 338 · cited 1×
“Finally, the algorithm we employed in the prediction module is a simple but effective predictor based on an autoregressive model of order one [40], whose key feature is the real-time estimation of the predictor’s parameters using a recursive least squares implementation, exploiting a forgetting…”
MethodSelf-citationPerformance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use
Gross, T. M., Bode, B. W., Einhorn, D., Kayne, D. M., Reed, J. H., White, N. H., & Mastrototaro, J. J. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/152091500316737 · Cited by 303
Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
Kovatchev, B. P., Patek, S. D., Ortiz, E. A., & Breton, M. D. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0272 · Cited by 234 · cited 2×
“Only Kovatchev et al. [47] explicitly addressed this problem and tried to give some indications on this topic.”
BackgroundComing of age: the artificial pancreas for type 1 diabetes
Thabit, H., & Hovorka, R. (2016) · Diabetologia · doi:10.1007/s00125-016-4022-4 · Cited by 223
Georga, E. I., Protopappas, V. C., Ardigo, D., Marina, M., Zavaroni, I., Polyzos, D., & Fotiadis, D. I. (2013) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/titb.2012.2219876 · Cited by 216 · cited 1×
“…can be employed, e.g., those of Zhao et al. [9,12], Zecchin et al. [13,41], Turksoy et al. [10], Zarkogianni et al. [11], and Georga et al. [42,43] The algorithmically “smart” CGM sensor concept has been validated on a dataset consisting of 23 T1D individuals whose glucose concentrations…”
MethodBode, B., Gross, K., Rikalo, N., Schwartz, S., Wahl, T., Page, C., Gross, T., & Mastrototaro, J. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504773731285 · Cited by 190 · cited 1×
“Since then, CGM sensors have been constantly improved by adding new features: the real-time visualization of glucose concentration value and its trend [2], the generation of acoustic and visual alerts when settable hypoglycemic and hyperglycemic thresholds are overcome [3], the increase in”
BackgroundFeldman, B., Brazg, R., Schwartz, S., & Weinstein, R. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503322526978 · Cited by 184 · cited 1×
“Since then, CGM sensors have been constantly improved by adding new features: the real-time visualization of glucose concentration value and its trend [2], the generation of acoustic and visual alerts when settable hypoglycemic and hyperglycemic thresholds are overcome [3], the increase in”
BackgroundChallenges and recent progress in the development of a closed-loop artificial pancreas
Bequette, B. W. (2012) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2012.09.007 · Cited by 183
The artificial pancreas: current status and future prospects in the management of diabetes
Peyser, T., Dassau, E., Breton, M., & Skyler, J. S. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12431 · Cited by 169
Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm
Bailey, T. S., Chang, A., & Christiansen, M. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814559746 · Cited by 168 · cited 1×
“…signal processing code was released by Dexcom Inc. under the name of “software 505”, which allowed by itself (i.e., without changing any hardware component) to reduce the MARD of the G4 Platinum from 13% to 9% [5,44,45], making this, in 2014, device the first CGM sensor reaching one-digit accuracy.”
MethodChristiansen, M., Bailey, T., Watkins, E., Liljenquist, D., Price, D., Nakamura, K., Boock, R., & Peyser, T. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0077 · Cited by 136 · cited 1×
“…signal processing code was released by Dexcom Inc. under the name of “software 505”, which allowed by itself (i.e., without changing any hardware component) to reduce the MARD of the G4 Platinum from 13% to 9% [5,44,45], making this, in 2014, device the first CGM sensor reaching one-digit accuracy.”
MethodZarkogianni, K., Mitsis, K., Litsa, E. E., Arredondo, M. T., Fico, G., Fioravanti, A., & Nikita, K. S. (2015) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-015-1320-9 · Cited by 133 · cited 1×
“…injected or physical activity, can be employed, e.g., those of Zhao et al. [9,12], Zecchin et al. [13,41], Turksoy et al. [10], Zarkogianni et al. [11], and Georga et al. [42,43] The algorithmically “smart” CGM sensor concept has been validated on a dataset consisting of 23 T1D individuals whose…”
MethodModeling the glucose sensor error
Facchinetti, A., Del Favero, S., Sparacino, G., Castle, J. R., Ward, W. K., & Cobelli, C. (2014) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2013.2284023 · Cited by 130 · cited 1×
“…of the calibration error, and the variability of the random noise component by sampling from appropriate distributions as described in depth in [57–59]; (C) a model of treatment rules and subject behavior , able to reproduce all the variability in the habits of the diabetic patients and in…”
MethodSelf-citationMastrototaro, J., Shin, J., Marcus, A., Sulur, G., & for the STAR 1 Clinical Trial Investigators (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0291 · Cited by 118 · cited 1×
“From a clinical point of view, it has been widely demonstrated that the additional information provided by CGM sensors, when used in conjunction with SMBG data, improves the quality of glucose control [7,8].”
BackgroundZecchin, C., Facchinetti, A., Sparacino, G., & Cobelli, C. (2013) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2013.09.016 · Cited by 114 · cited 1×
“…other signals like the amount of insulin injected or physical activity, can be employed, e.g., those of Zhao et al. [9,12], Zecchin et al. [13,41], Turksoy et al. [10], Zarkogianni et al. [11], and Georga et al. [42,43] The algorithmically “smart” CGM sensor concept has been validated on a…”
MethodSelf-citationCircadian Variability of Insulin Sensitivity: Physiological Input for In Silico Artificial Pancreas
Visentin, R., Dalla Man, C., Kudva, Y. C., Basu, A., & Cobelli, C. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0192 · Cited by 113 · cited 1×
“Recently, thanks to the development and embedding of inter- and intra-day variability of the insulin sensitivity, the new version of the UVA/Padova T1D simulator allows for generating physiological glucose profiles of T1D on multiple-day scenarios [54,55];”
MethodGeorga, E. I., Protopappas, V. C., Polyzos, D. K., & Fotiadis, D. I. (2015) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-015-1263-1 · Cited by 110 · cited 1×
“…can be employed, e.g., those of Zhao et al. [9,12], Zecchin et al. [13,41], Turksoy et al. [10], Zarkogianni et al. [11], and Georga et al. [42,43] The algorithmically “smart” CGM sensor concept has been validated on a dataset consisting of 23 T1D individuals whose glucose concentrations were…”
MethodReal-Time Improvement of Continuous Glucose Monitoring Accuracy
Facchinetti, A., Sparacino, G., Guerra, S., Luijf, Y. M., DeVries, J. H., Mader, J. K., Ellmerer, M., Benesch, C., Heinemann, L., Bruttomesso, D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0736 · Cited by 106 · cited 5×
“These three key challenges have been overcome by the creation of the algorithmically “smart” CGM sensor, which consists of placing, in a cascade of the output of a commercial CGM sensor, three software modules for (i) denoising; (ii) enhancement; and (iii) prediction [27,28].”
BackgroundMethodInfluentialSelf-citationHypoglycemia Early Alarm Systems Based on Multivariable Models
Turksoy, K., Bayrak, E. S., Quinn, L., Littlejohn, E., Rollins, D., & Cinar, A. (2013) · Industrial & Engineering Chemistry Research · doi:10.1021/ie3034015 · Cited by 104 · cited 1×
“…the amount of insulin injected or physical activity, can be employed, e.g., those of Zhao et al. [9,12], Zecchin et al. [13,41], Turksoy et al. [10], Zarkogianni et al. [11], and Georga et al. [42,43] The algorithmically “smart” CGM sensor concept has been validated on a dataset consisting of…”
Method“Smart” Continuous Glucose Monitoring Sensors: On-Line Signal Processing Issues
Sparacino, G., Facchinetti, A., & Cobelli, C. (2010) · Sensors · doi:10.3390/s100706751 · Cited by 96 · cited 4×
“We have shown how the algorithmic open issues identified by Sparacino et al. [26] have been tackled by the creation of the “smart” CGM sensors, which allowed improving precision, accuracy and timeliness of hypo/hyperglycemic alerts of commercial CGM sensors.”
BackgroundMethodInfluentialSelf-citationPalerm, C. C., & Bequette, B. W. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100505 · Cited by 89 · cited 1×
“Other denoising algorithms that can be used here are those, e.g., of Chase et al. [31], Palerm and Bequette [32], Kuure-Kinsey et al. [33], and Mahmoudi et al. [34].”
MethodHughes, C. S., Patek, S. D., Breton, M. D., & Kovatchev, B. P. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400513 · Cited by 89
Visentin, R., Man, C. D., & Cobelli, C. (2016) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2535241 · Cited by 86
Facchinetti, A., Del Favero, S., Sparacino, G., & Cobelli, C. (2015) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-014-1226-y · Cited by 80
Self-citationA Novel Method to Detect Pressure-Induced Sensor Attenuations (PISA) in an Artificial Pancreas
Baysal, N., Cameron, F., Buckingham, B. A., Wilson, D. M., Chase, H. P., Maahs, D. M., Bequette, B. W., for the In Home Closed-Loop Study Group (IHCL), Buckingham, B. A., Wilson, D. M., et al. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814553267 · Cited by 78
Bailey, T., Zisser, H., & Chang, A. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0075 · Cited by 71 · cited 1×
“sensor duration [4], and reduction of hardware size [5], until it is possible to be connected directly to smart-phones and access glucose concentration data via remote monitoring [6].”
BackgroundEmpirical Representation of Blood Glucose Variability in a Compartmental Model
Patek, S. D., Lv, D., Ortiz, E. A., Karvetski, C., Kulkarni, S. D., Zhang, Q., & Breton, M. D. (2015) · Lecture notes in bioengineering · doi:10.1007/978-3-319-25913-0_8 · Cited by 65 · cited 1×
“By modifying retrospectively some CGM traces using the so-called “net-effect” model [48], the authors reached the preliminary conclusion that CGM sensors with MARD ≤ 10% could be suitable for insulin dosing decisions.”
MethodZecchin, C., Facchinetti, A., Sparacino, G., & Cobelli, C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816654161 · Cited by 64 · cited 1×
“…other signals like the amount of insulin injected or physical activity, can be employed, e.g., those of Zhao et al. [9,12], Zecchin et al. [13,41], Turksoy et al. [10], Zarkogianni et al. [11], and Georga et al. [42,43] The algorithmically “smart” CGM sensor concept has been validated on…”
MethodSelf-citationViceconti, M., Cobelli, C., Haddad, T., Himes, A., Kovatchev, B., & Palmer, M. (2017) · Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine · doi:10.1177/0954411917702931 · Cited by 64
Modeling Transient Disconnections and Compression Artifacts of Continuous Glucose Sensors
Facchinetti, A., Favero, S. D., Sparacino, G., & Cobelli, C. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0250 · Cited by 63
Self-citationFacchinetti, A., Favero, S., Sparacino, G., & Cobelli, C. (2013) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2012.2227256 · Cited by 62
Self-citationAn Online Self-Tunable Method to Denoise CGM Sensor Data
Facchinetti, A., Sparacino, G., & Cobelli, C. (2010) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2009.2033264 · Cited by 62 · cited 1×
“In the implementation, we proposed in Facchinetti et al. [27], that the denoising module contained an adaptive self-tunable Bayesian smoother [29,30] able to automatically estimate in real time the signal-to-noise ratio present on the CGM data and able to perform an optimal and computationally…”
MethodSelf-citationEnhancing the Accuracy of Subcutaneous Glucose Sensors: A Real-Time Deconvolution-Based Approach
Guerra, S., Facchinetti, A., Sparacino, G., De Nicolao, G., & Cobelli, C. (2012) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2012.2191782 · Cited by 61 · cited 1×
“With regard to the enhancement module, we proposed a stochastic deconvolution-based re-calibration algorithm [35], which re-scales the CGM data using a simple linear regressor whose parameters are re-calculated every time a new SMBG value is available.”
MethodSelf-citationZhao, C., Dassau, E., Jovanovič, L., Zisser, H. C., Doyle, F. J., & Seborg, D. E. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600317 · Cited by 60 · cited 1×
“…algorithms, also exploiting other signals like the amount of insulin injected or physical activity, can be employed, e.g., those of Zhao et al. [9,12], Zecchin et al. [13,41], Turksoy et al. [10], Zarkogianni et al. [11], and Georga et al. [42,43] The algorithmically “smart” CGM sensor concept…”
MethodFault Detection and Safety in Closed-Loop Artificial Pancreas Systems
Bequette, B. W. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814543661 · Cited by 60
Facchinetti, A., Sparacino, G., & Cobelli, C. (2011) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2011.2161083 · Cited by 58 · cited 1×
“[27], that the denoising module contained an adaptive self-tunable Bayesian smoother [29,30] able to automatically estimate in real time the signal-to-noise ratio present on the CGM data and able to perform an optimal and computationally efficient real-time smoothing thanks to a Kalman filter-based implementation.”
MethodSelf-citationNonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions
Castle, J. R., & Jacobs, P. G. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816631569 · Cited by 56 · cited 1×
“It is becoming a common perception that CGM sensors are accurate enough to be used for therapeutic decisions [46] and the academic research is now focused on this new challenge, i.e., demonstrating both the safety and efficacy of CGM sensors for the nonadjunctive use.”
BackgroundInpatient Studies of a Kalman-Filter-Based Predictive Pump Shutoff Algorithm
Cameron, F., Wilson, D. M., Buckingham, B. A., Arzumanyan, H., Clinton, P. K., Chase, H. P., Lum, J. W., Maahs, D. M., Calhoun, P. M., & Bequette, B. W. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600519 · Cited by 56
A Dual-Rate Kalman Filter for Continuous Glucose Monitoring
Kuure-Kinsey, M., Palerm, C. C., & Bequette, B. W. (2006) · 2006 International Conference of the IEEE Engineering in Medicine and Biology Society · doi:10.1109/iembs.2006.260057 · Cited by 56
Robust Fault Detection System for Insulin Pump Therapy Using Continuous Glucose Monitoring
Herrero, P., Calm, R., Vehí, J., Armengol, J., Georgiou, P., Oliver, N., & Tomazou, C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600518 · Cited by 52 · cited 1×
“Some algorithms for fault detection have been presented in the literature [17–21], but they are still prototypes, and more investigation is required on their effectiveness before porting them into AP systems.”
MethodEarly Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes
Cescon, M., DeSalvo, D. J., Ly, T. T., Maahs, D. M., Messer, L. H., Buckingham, B. A., Doyle, F. J., & Dassau, E. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816663962 · Cited by 52 · cited 1×
“Some algorithms for fault detection have been presented in the literature [17–21], but they are still prototypes, and more investigation is required on their effectiveness before porting them into AP systems.”
Regulation Catches Up to Reality: Nonadjunctive Use of Continuous Glucose Monitoring Data
Edelman, S. V. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816667749 · Cited by 51 · cited 1×
“FDA’s Medical Device Advisory Committee on 21 July 2016 to ask for a change of label for the G5 Mobile device from adjunctive to nonadjunctive use [60,61].”
BackgroundChase, J. G., Hann, C. E., Jackson, M. I., Lin, J., Lotz, T., Wong, X., & Shaw, G. M. (2006) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2006.03.004 · Cited by 49 · cited 1×
“[31], Palerm and Bequette [32], Kuure-Kinsey et al.”
BackgroundPrediction Methods for Blood Glucose Concentration
Kirchsteiger, H., Jørgensen, J. B., Renard, É., & del Re, L. (2015) · Lecture notes in bioengineering · doi:10.1007/978-3-319-25913-0 · Cited by 48
Zhao, C., & Yu, C. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2014.2387293 · Cited by 47
Dexcom G4AP: An Advanced Continuous Glucose Monitor for the Artificial Pancreas
Garcia, A., Rack-Gomer, A. L., Bhavaraju, N. C., Hampapuram, H., Kamath, A., Peyser, T., Facchinetti, A., Zecchin, C., Sparacino, G., & Cobelli, C. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700604 · Cited by 47
Self-citationFDA Advisory Panel Votes to Recommend Non-Adjunctive Use of Dexcom G5 Mobile CGM
(2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.07252.mr · Cited by 47 · cited 1×
“FDA’s Medical Device Advisory Committee on 21 July 2016 to ask for a change of label for the G5 Mobile device from adjunctive to nonadjunctive use [60,61].”
BackgroundReal-Time Model-Based Fault Detection of Continuous Glucose Sensor Measurements
Turksoy, K., Roy, A., & Çınar, A. (2016) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2535412 · Cited by 38
A Multiple Local Models Approach to Accuracy Improvement in Continuous Glucose Monitoring
Barceló-Rico, F., Bondía, J., Díez, J.-L., & Rossetti, P. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0138 · Cited by 34
Adaptive Calibration Algorithm for Plasma Glucose Estimation in Continuous Glucose Monitoring
Barceló-Rico, F., Díez, J.-L., Rossetti, P., Vehí, J., & Bondía, J. (2013) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2013.2253325 · Cited by 34 · cited 1×
“Other enhancement/recalibration algorithms that can be exploited in this module are, e.g., those of Barcelo-Rico et al. [37,38], Mahmoudi et al. [34], and Kirchsteiger et al. [39].”
MethodMahmoudi, Z., Johansen, M. D., Christiansen, J. S., & Hejlesen, O. K. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0041 · Cited by 30 · cited 2×
“Other enhancement/recalibration algorithms that can be exploited in this module are, e.g., those of Barcelo-Rico et al. [37,38], Mahmoudi et al. [34], and Kirchsteiger et al. [39].”
MethodVettoretti, M., Facchinetti, A., Favero, S. D., Sparacino, G., & Cobelli, C. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2015.2426217 · Cited by 28
Self-citationAcciaroli, G., Vettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0088 · Cited by 22 · cited 1×
“In a recent study of our group [64], we demonstrated that the number of calibrations can be reduced from two to one per day thanks to the use of the new calibrations functions that allow taking into account the variability in”
BackgroundSelf-citationFacchinetti, A., Sparacino, G., & Cobelli, C. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700522 · Cited by 20 · cited 1×
“These three key challenges have been overcome by the creation of the algorithmically “smart” CGM sensor, which consists of placing, in a cascade of the output of a commercial CGM sensor, three software modules for (i) denoising; (ii) enhancement; and (iii) prediction [27,28].”
BackgroundSelf-citationThe artificial pancreas: a digital-age treatment for diabetes
Cobelli, C., Renard, É., & Kovatchev, B. P. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70126-3 · Cited by 18
Vettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C. (2015) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2015.7318868 · Cited by 18 · cited 5×
“To prove the safety and effectiveness of the nonadjunctive use of CGM sensors, our research group is developing the T1D decision-making (T1D-DM) model, i.e., a model of T1D patients making SMBG-based or CGM-based treatment decisions, like insulin dosing or CHO intake [51].”
BackgroundMethodInfluentialSelf-citationInpatient studies of a Kalman-filter-based predictive pump shutoff algorithm
Cameron, F., Wilson, D. M., Buckingham, B. A., Arzumanyan, H., Clinton, P. K., Chase, H. P., Lum, J. W., Maahs, D. M., Calhoun, P. M., & Bequette, B. W. (2012) · Diabetes Technology & Therapeutics · Cited by 17
LMI-Based Approaches for the Calibration of Continuous Glucose Measurement Sensors
Kirchsteiger, H., Zaccarian, L., Renard, É., & del Re, L. (2014) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2014.2341703 · Cited by 15
Predicting Insulin Treatment Scenarios with the Net Effect Method: Domain of Validity
Vettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0148 · Cited by 13
Self-citationWeiss, R., Garg, S. K., Bergenstal, R. M., Klonoff, D. C., Bode, B. W., Bailey, T. S., Thrasher, J. R., Schwartz, F., Welsh, J. B., KAUFMAN, F. R., et al. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815586014 · Cited by 12
Monitoring and fault detection of continuous glucose sensor measurements
Turksoy, K., Quinn, L., Littlejohn, E., & Çınar, A. (2015) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.1109/acc.2015.7172133 · Cited by 11
Accuracy of devices for self-monitoring of blood glucose: A stochastic error model
Vettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C. (2015) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2015.7318867 · Cited by 6 · cited 1×
“The SMBG measurement error is sampled from a composite distribution obtained combining a skew-normal density function, to describe the central part of the distribution, the exponential functions, and the tails [56].”
MethodSelf-citation
Cited by
Electrochemical glucose sensors in diabetes management: an updated review (2010–2020)
Teymourian, H., Barfidokht, A., & Wang, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00304b · Cited by 881
Villena Gonzales, W., Mobashsher, A., & Abbosh, A. (2019) · Sensors · doi:10.3390/s19040800 · Cited by 772
“As a result, these and many other unsuccessful outcomes have left many wondering if it is possible to measure glucose in a way that doesn’t need any blood drawn out of the body.”
BackgroundMethodCappon, G., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0121 · Cited by 477
Self-citationWearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review
Saha, T., Del Caño, R., Mahato, K., De la Paz, E., Chen, C., Ding, S., Yin, L., & Wang, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00078 · Cited by 442
Wearable Electrochemical Sensors for the Monitoring and Screening of Drugs
Teymourian, H., Parrilla, M., Sempionatto, J. R., Montiel, N. F., Barfidokht, A., Van Echelpoel, R., De Wael, K., & Wang, J. (2020) · ACS Sensors · doi:10.1021/acssensors.0c01318 · Cited by 423
Metadata
- Authors
- Facchinetti, A.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Facchinetti, Andrea
- ORCID
- Facchinetti, Andrea
- Venue
- Sensors
- Publisher
- MDPI AG
- Published
- 2016-12-09
- Volume
- 16
- Issue
- 12
- Pages
- 2093
- ISSN
- 1424-8220 (ISSN-L)
- PMC
- PMC5191073
- OpenAlex
- W2560030487
- Cited by
- 176
- References
- 68
- Citations by year
- 2026: 14 · 2025: 16 · 2024: 8 · 2023: 17 · 2022: 17 · 2021: 16 · 2020: 22 · 2019: 25 · 2018: 19 · 2017: 22
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Sensors (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Physical Sciences › Chemistry › Analytical Chemistry › Electrochemical sensors and biosensors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- continuous glucose monitoring, type 1 diabetes, glucose prediction, hypoglycemia prediction, artificial pancreas, signal processing algorithms, sensor accuracy and reliability
- MeSH terms
- Clinical Decision-Making, Algorithms, Diabetes Mellitus, Type 1, Humans, Software, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.